Investor Panels


Venture capitalists are dying, long live VCs

How angels and micro-VCs are changing the funding landscape

Innovation series by Bambi Francisco Roizen
February 23, 2012 | Comments
Short URL:

If you want to get a sense of how early-stage investors feel they're affecting the venture ecosystem, watch this panel. At Venture Shift NY, hosted by Vator and Bullpen Capital, we brought together some high-profile and prolific investors to talk about their impact on a panel titled "How Angels and Super Angels/Micro-Cap VC Funds are Changing Stakes and Creating a New Ecosystem."

John Borthwick, from Betaworks, said it best: "VCs are dying." Essentially, what we've seen in the last decade is a consolidation of VCs and "shitty" returns out of the ones who raised funds in the first five years of the 21st century. At the same time, there are new investors emerging, particularly in the early stages that have new models and frameworks that differ from the old VC model. Betaworks is not a fund, but rather a company. It's investment activity is informed by what the team tries to build. And, their focus is very tightly around "social real-time." Their investments come out of their balance sheet. 

Indeed, Betaworks is a pretty unique entity across the early-stage spectrum. TechStars is also a new breed of early-stage investor, though it's been around for several years. The TechStars fund is funded by 75 VCs. "We're in the business of getting our companies funded by other people," said David Tisch, who heads up TechStars in NY.

All the panelists made some great points about the ecosystem. So, what are you waiting for? Just watch the video.

Joining Borthwick and Tisch were Roger Erhenberg (IA Ventures), Owen Davis (NYC Seed), and David Teten (ff Venture Capital), with Bruce Taragin of Blumberg Capital moderating. 

Related companies, investors and entrepreneurs

Bullpen Capital
Angel group/VC
Description: Bullpen Capital is second round investor who invests in companies previously seeded by the Super Angel funds.
Bio: Bruce has 17 years experience as a venture capital investor, entrepreneur, technology investment banker and corporate attorney.  P...
David Teten
ff Venture Capital
Bio: David Teten is a Partner with ff Venture Capital, Founder and Chairman of Harvard Business School Angels New York, and co-...
Bio: As Director of TechStars in New York City, David will co-lead the New York City TechStars program alongside TechStars’ Founder and ...
blog comments powered by Disqus

Featured Stories

Other episodes of this series

In a market slide, a flat 'investment'...


Investor Panels

by Steven Loeb
Our panel at Spash weighed in on whether or not there's a market slide, with most of them saying yes

Who's financing the digital health ecosystem?


Investor Panels

by Mitos Suson
At Vator Splash Health 2016, KPMG's Mark Ginestro moderated panel on healthtech investing trends

Glooko, Propeller Health, Enlitic on...


Investor Panels

by Mitos Suson
At Vator Splash Health 2016, Vator's Roman Arzhintar leads talk on patient-engagement

Pokitdok, Box, Validic, Human API: New data...


Investor Panels

by Mitos Suson
At Vator Splash Health 2016, Subtraction Capital leads discussion on uncovering new data

Innovators in patient-centered healthcare


Investor Panels

by Mitos Suson
At Vator Splash Health 2016